Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea

Table 2 Standardized mortality ratio (SMR)

Fracture status		SMR	Reference
Mortality of the general population		Reference	KOSIS
No new fracture		1	-
Vertebral fracture^a	Male	4.56	[24]
Vertebral fracture^a	Female	2.99	[24]
Non-vertebral fracture^b	Male	5.02	[25]
Non-vertebral fracture^b	Female	3.29	[25]

^aSMR at 6 months after vertebral fracture in men and women; ^bYoo et al. presented the mortality HR (hazard ratio) of non-VF compared to that of VF [humerus (1.41), wrist (0.52), and hip (1.68)]. The final non-VF SMR was calculated by multiplying the SMR od VF by the weighted HR of non-VF compared to VF; VF: vertebral fracture; KOSIS: Korean Statistical Information Service

ISSN: 1471-2474